1. Home
  2. MNY vs FORA Comparison

MNY vs FORA Comparison

Compare MNY & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MoneyHero Limited

MNY

MoneyHero Limited

HOLD

Current Price

$1.31

Market Cap

58.9M

Sector

N/A

ML Signal

HOLD

Logo Forian Inc.

FORA

Forian Inc.

HOLD

Current Price

$2.16

Market Cap

67.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNY
FORA
Founded
2014
2014
Country
Singapore
United States
Employees
240
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
58.9M
67.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
MNY
FORA
Price
$1.31
$2.16
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.00
N/A
AVG Volume (30 Days)
20.4K
62.6K
Earning Date
04-30-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.00
EPS
N/A
N/A
Revenue
N/A
$30,256,919.00
Revenue This Year
N/A
$8.44
Revenue Next Year
$19.58
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
50.13
52 Week Low
$0.66
$1.64
52 Week High
$2.40
$2.71

Technical Indicators

Market Signals
Indicator
MNY
FORA
Relative Strength Index (RSI) 46.45 64.06
Support Level $1.31 $2.05
Resistance Level $1.52 $2.20
Average True Range (ATR) 0.04 0.01
MACD -0.00 -0.00
Stochastic Oscillator 38.46 66.67

Price Performance

Historical Comparison
MNY
FORA

About MNY MoneyHero Limited

MoneyHero Ltd is a tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia. It operates in Singapore, Hong Kong, Taiwan and the Philippines. Its brand portfolio includes B2C platforms MoneyHero, SingSaver, Money101, Moneymax and Seedly, as well as the B2B platform Creatory. The company has four operating and reportable segments: Hong Kong, Singapore, the Philippines, and Taiwan. The Hong Kong segment generates the majority of the revenue.

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

Share on Social Networks: